Logo image of CALX

CALIX INC (CALX) Stock Fundamental Analysis

USA - NYSE:CALX - US13100M5094 - Common Stock

61.37 USD
0 (0%)
Last: 10/1/2025, 8:27:19 PM
61.37 USD
0 (0%)
After Hours: 10/1/2025, 8:27:19 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CALX. CALX was compared to 48 industry peers in the Communications Equipment industry. No worries on liquidiy or solvency for CALX as it has an excellent financial health rating, but there are worries on the profitability. CALX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

In the past year CALX was profitable.
In the past year CALX had a positive cash flow from operations.
Of the past 5 years CALX 4 years were profitable.
Each year in the past 5 years CALX had a positive operating cash flow.
CALX Yearly Net Income VS EBIT VS OCF VS FCFCALX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

CALX's Return On Assets of -2.92% is in line compared to the rest of the industry. CALX outperforms 43.75% of its industry peers.
CALX has a Return On Equity (-3.48%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA -2.92%
ROE -3.48%
ROIC N/A
ROA(3y)1.53%
ROA(5y)8.91%
ROE(3y)2.1%
ROE(5y)12.04%
ROIC(3y)N/A
ROIC(5y)N/A
CALX Yearly ROA, ROE, ROICCALX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40

1.3 Margins

CALX's Gross Margin of 55.50% is fine compared to the rest of the industry. CALX outperforms 77.08% of its industry peers.
In the last couple of years the Gross Margin of CALX has grown nicely.
The Profit Margin and Operating Margin are not available for CALX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 55.5%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.29%
GM growth 5Y4.26%
CALX Yearly Profit, Operating, Gross MarginsCALX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40

More info and screens

8

2. Health

2.1 Basic Checks

CALX does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CALX has been increased compared to 1 year ago.
CALX has more shares outstanding than it did 5 years ago.
CALX has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
CALX Yearly Shares OutstandingCALX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
CALX Yearly Total Debt VS Total AssetsCALX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.2 Solvency

CALX has an Altman-Z score of 16.95. This indicates that CALX is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of CALX (16.95) is better than 91.67% of its industry peers.
There is no outstanding debt for CALX. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 16.95
ROIC/WACCN/A
WACC9.81%
CALX Yearly LT Debt VS Equity VS FCFCALX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M

2.3 Liquidity

A Current Ratio of 4.55 indicates that CALX has no problem at all paying its short term obligations.
The Current ratio of CALX (4.55) is better than 89.58% of its industry peers.
CALX has a Quick Ratio of 3.65. This indicates that CALX is financially healthy and has no problem in meeting its short term obligations.
CALX's Quick ratio of 3.65 is amongst the best of the industry. CALX outperforms 87.50% of its industry peers.
Industry RankSector Rank
Current Ratio 4.55
Quick Ratio 3.65
CALX Yearly Current Assets VS Current LiabilitesCALX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for CALX have decreased strongly by -37.29% in the last year.
CALX shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 53.42% yearly.
CALX shows a decrease in Revenue. In the last year, the revenue decreased by -8.80%.
Measured over the past years, CALX shows a quite strong growth in Revenue. The Revenue has been growing by 14.40% on average per year.
EPS 1Y (TTM)-37.29%
EPS 3Y-28.24%
EPS 5Y53.42%
EPS Q2Q%277.78%
Revenue 1Y (TTM)-8.8%
Revenue growth 3Y6.97%
Revenue growth 5Y14.4%
Sales Q2Q%22.08%

3.2 Future

Based on estimates for the next years, CALX will show a very strong growth in Earnings Per Share. The EPS will grow by 68.69% on average per year.
CALX is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 13.38% yearly.
EPS Next Y134.2%
EPS Next 2Y81.72%
EPS Next 3Y68.69%
EPS Next 5YN/A
Revenue Next Year15.51%
Revenue Next 2Y12.77%
Revenue Next 3Y13.38%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
CALX Yearly Revenue VS EstimatesCALX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
CALX Yearly EPS VS EstimatesCALX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 1 -1 2

More info and screens

3

4. Valuation

4.1 Price/Earnings Ratio

CALX is valuated quite expensively with a Price/Earnings ratio of 82.93.
CALX's Price/Earnings is on the same level as the industry average.
CALX's Price/Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 27.79.
CALX is valuated quite expensively with a Price/Forward Earnings ratio of 36.44.
The rest of the industry has a similar Price/Forward Earnings ratio as CALX.
The average S&P500 Price/Forward Earnings ratio is at 23.21. CALX is valued rather expensively when compared to this.
Industry RankSector Rank
PE 82.93
Fwd PE 36.44
CALX Price Earnings VS Forward Price EarningsCALX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 50 100 150

4.2 Price Multiples

CALX's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 56.03
EV/EBITDA N/A
CALX Per share dataCALX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6 8 10

4.3 Compensation for Growth

CALX's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CALX's earnings are expected to grow with 68.69% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.62
PEG (5Y)1.55
EPS Next 2Y81.72%
EPS Next 3Y68.69%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for CALX!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

CALIX INC

NYSE:CALX (10/1/2025, 8:27:19 PM)

After market: 61.37 0 (0%)

61.37

0 (0%)

Chartmill FA Rating
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryCommunications Equipment
Earnings (Last)07-21 2025-07-21/amc
Earnings (Next)10-27 2025-10-27/amc
Inst Owners88.05%
Inst Owner Change-2.16%
Ins Owners10.44%
Ins Owner Change0.53%
Market Cap4.01B
Analysts80
Price Target66.6 (8.52%)
Short Float %3.86%
Short Ratio3.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)52.89%
Min EPS beat(2)47.06%
Max EPS beat(2)58.73%
EPS beat(4)4
Avg EPS beat(4)38.71%
Min EPS beat(4)7.65%
Max EPS beat(4)58.73%
EPS beat(8)7
Avg EPS beat(8)28.07%
EPS beat(12)11
Avg EPS beat(12)27.11%
EPS beat(16)15
Avg EPS beat(16)23.57%
Revenue beat(2)2
Avg Revenue beat(2)5.13%
Min Revenue beat(2)4.32%
Max Revenue beat(2)5.95%
Revenue beat(4)2
Avg Revenue beat(4)1.84%
Min Revenue beat(4)-2.02%
Max Revenue beat(4)5.95%
Revenue beat(8)2
Avg Revenue beat(8)-0.57%
Revenue beat(12)3
Avg Revenue beat(12)0.15%
Revenue beat(16)6
Avg Revenue beat(16)0.32%
PT rev (1m)0%
PT rev (3m)26.05%
EPS NQ rev (1m)0%
EPS NQ rev (3m)45.53%
EPS NY rev (1m)0%
EPS NY rev (3m)33.83%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)8.4%
Revenue NY rev (1m)0%
Revenue NY rev (3m)6.21%
Valuation
Industry RankSector Rank
PE 82.93
Fwd PE 36.44
P/S 4.61
P/FCF 56.03
P/OCF 45.56
P/B 5.19
P/tB 6.1
EV/EBITDA N/A
EPS(TTM)0.74
EY1.21%
EPS(NY)1.68
Fwd EY2.74%
FCF(TTM)1.1
FCFY1.78%
OCF(TTM)1.35
OCFY2.19%
SpS13.31
BVpS11.83
TBVpS10.05
PEG (NY)0.62
PEG (5Y)1.55
Profitability
Industry RankSector Rank
ROA -2.92%
ROE -3.48%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 55.5%
FCFM 8.23%
ROA(3y)1.53%
ROA(5y)8.91%
ROE(3y)2.1%
ROE(5y)12.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.29%
GM growth 5Y4.26%
F-Score6
Asset Turnover0.94
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr 90.44%
Cap/Sales 1.89%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.55
Quick Ratio 3.65
Altman-Z 16.95
F-Score6
WACC9.81%
ROIC/WACCN/A
Cap/Depr(3y)99.33%
Cap/Depr(5y)84.93%
Cap/Sales(3y)1.84%
Cap/Sales(5y)1.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-37.29%
EPS 3Y-28.24%
EPS 5Y53.42%
EPS Q2Q%277.78%
EPS Next Y134.2%
EPS Next 2Y81.72%
EPS Next 3Y68.69%
EPS Next 5YN/A
Revenue 1Y (TTM)-8.8%
Revenue growth 3Y6.97%
Revenue growth 5Y14.4%
Sales Q2Q%22.08%
Revenue Next Year15.51%
Revenue Next 2Y12.77%
Revenue Next 3Y13.38%
Revenue Next 5YN/A
EBIT growth 1Y-270.01%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year257.36%
EBIT Next 3Y92.18%
EBIT Next 5YN/A
FCF growth 1Y256.04%
FCF growth 3Y2.81%
FCF growth 5YN/A
OCF growth 1Y129.08%
OCF growth 3Y6.39%
OCF growth 5Y71.21%